Drug · DIN 02409909
SDZ-SUMATRIPTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 1, 2019.
- Drug Identification Number (DIN)
- 02409909
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 15, 2013: NOC 14652Abbreviated New Drug Submission (ANDS) · Administrative additional product name
Other DINs named SDZ-SUMATRIPTAN
- DIN 02409917 · Cancelled Pre Market